Chemical Structure : ARCC-4
CAS No.: 1973403-00-7
Catalog No.: PC-22554Not For Human Use, Lab Use Only.
ARCC-4 is a potent, selective enzalutamide-based von Hippel-Lindau (VHL)-recruiting androgen receptor (AR) degrader with DC50 of 5 nM in VCaP cells.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $328 | In stock | |
10 mg | $528 | In stock | |
25 mg | Get quote | ||
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ARCC-4 is a potent, selective enzalutamide-based von Hippel-Lindau (VHL)-recruiting androgen receptor (AR) degrader with DC50 of 5 nM in VCaP cells.
ARCC-4 is better at overcoming resistance in cellular models of castration-resistant prostate cancer (CRPC).
ARCC-4 is better than enzalutamide at inducing apoptosis and inhibiting proliferation of AR-amplified prostate cancer cells.
ARCC-4 effectively degrades clinically relevant AR mutants associated with antiandrogen therapy, and maintains its potency to degrade AR and inhibit cell proliferation in a high androgen environment in which enzalutamide has no activity.
M.Wt | 1024.18 | |
Formula | C53H56F3N7O7S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(2S,4R)-1-((S)-2-(2-(4-((4'-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-[1,1'-biphenyl]-4-yl)oxy)butoxy)acetamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide |
1. Salami J, et al. Commun Biol. 2018 Aug 2;1:100.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright